Clinical Trial: A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Single-Ascending Dose Study of LY3872386 in Healthy Participants, a Multiple-Ascending Dose Study of LY3872386 in Patients With At
Brief Summary:
The main purpose of this study is to evaluate the safety and tolerability of LY3872386 in healthy participants and participants with atopic dermatitis.The safety of prednisone is also evaluated in healthy participants.Blood tests will be performed to investigate how the body processes the LY3872386 following single and multiple dosing in healthy participants and participants with atopic dermatitis.Blood tests will also be performed to investigate how the body processes the prednisone in healthy participants.The…
Read more